Novartis AG (NVS) shareholders
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.25−0.07 (-0.04%)
Close on Nov 12, 2026Market cap $305.78BP/E 22.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
136M
Shares held, 13F filers
Institutional holders
1,618
132 new, 88 sold out
Net institutional buying
-6M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 145,227,650 | 7.10% | 13G (passive) amendment | Sep 30, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 139,602,467 | 6.40% | 13G (passive) | Sep 30, 2024 |
| Novartis BidCo AG Joint filing with Novartis BidCo Germany AG (100.00%), Novartis Pharma AG (100.00%) and 1 more | 37,716,423 | 100.00% | 13D (active) amendment | Oct 15, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NVS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Fisher Asset Management, LLC | 15,523,378 | – | $2.43B | +1,637,629 | 0.72% |
| Morgan Stanley | 8,726,827 | – | $1.37B | +199,790 | 0.07% |
| Dimensional Fund Advisors LP | 8,117,586 | – | $1.27B | +7,470 | 0.23% |
| Primecap Management Co/Ca/ | 6,592,124 | – | $1.03B | −975,230 | 0.61% |
| Loomis Sayles & Co L P | 5,239,309 | – | $821.10M | −186,791 | 1.03% |
| Bank Of America Corp /De/ | 4,909,938 | – | $769.49M | −52,856 | 0.05% |
| Franklin Resources Inc | 3,251,281 | – | $509.54M | −158,663 | 0.11% |
| BlackRock, Inc. | 3,047,988 | – | $477.68M | +98,228 | 0.01% |
| Goldman Sachs Group Inc | 2,980,168 | – | $467.05M | −3,545,603 | 0.04% |
| Northern Trust Corp | 2,792,745 | – | $437.68M | +6,517 | 0.05% |
| Natixis Advisors, L.P. | 2,386,527 | – | $374.02M | +150,371 | 0.42% |
| Envestnet Asset Management Inc | 2,330,979 | – | $365.31M | +19,595 | 0.09% |
| JPMorgan Chase & Co | 2,264,447 | – | $356.85M | +459,771 | 0.02% |
| Jupiter Topco LLC | 2,221,362 | – | $348.13M | New | 0.14% |
| GQG Partners LLC | 2,151,131 | – | $337.13M | −296,141 | 0.63% |
| FMR LLC | 2,057,404 | – | $322.44M | +364,411 | 0.01% |
| Cullen Capital Management, LLC | 2,033,040 | – | $318.62M | −4,922 | 3.13% |
| Jones Financial Companies Lllp | 1,974,043 | – | $306.81M | +152,247 | 0.12% |
| Wcm Investment Management, LLC | 1,904,349 | – | $300.11M | +441,169 | 0.54% |
| Wells Fargo & Company/Mn | 1,828,817 | – | $286.61M | −66,860 | 0.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,618 | 136M | 132 / 530 | 572 / 88 | 12M | 18M |
| Q1 2026 | 1,601 | 144M | 198 / 534 | 549 / 87 | 24M | 13M |
| Q4 2025 | 1,510 | 134M | 207 / 496 | 478 / 67 | 11M | 11M |
| Q3 2025 | 1,402 | 135M | 116 / 477 | 483 / 74 | 10M | 9M |
| Q2 2025 | 1,385 | 134M | 119 / 496 | 475 / 75 | 9M | 13M |
| Q1 2025 | 1,358 | 139M | 121 / 428 | 509 / 80 | 19M | 10M |
| Q4 2024 | 1,341 | 130M | 158 / 419 | 468 / 106 | 8M | 9M |
| Q3 2024 | 1,312 | 132M | 101 / 411 | 483 / 79 | 7M | 11M |
| Q2 2024 | 1,307 | 138M | 133 / 427 | 489 / 65 | 8M | 24M |
| Q1 2024 | 1,252 | 155M | 89 / 424 | 471 / 94 | 16M | 9M |
| Q4 2023 | 1,273 | 148M | 140 / 405 | 446 / 69 | 16M | 16M |
| Q3 2023 | 1,224 | 149M | 97 / 373 | 450 / 60 | 6M | 7M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
142 funds held NVS in Q2 2026, 7% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NVS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Primecap Fund | 4,252,875 | – | $666.51M | 0.69% | Jun 30, 2026 |
| International Core Equity 2 Portfolio | 2,060,639 | – | $321.77M | 0.76% | Jul 31, 2026 |
| Loomis Sayles Growth Fund | 1,417,894 | – | $222.21M | 1.35% | Jun 30, 2026 |
| Vanguard Capital Opportunity Fund | 1,211,220 | – | $189.82M | 0.58% | Jun 30, 2026 |
| Franklin Mutual Global Discovery Fund | 1,192,174 | – | $186.84M | 2.07% | Jun 30, 2026 |
| Janus Henderson Global Life Sciences Fund | 949,726 | – | $148.84M | 2.56% | Jun 30, 2026 |
| Equity Income Fund | 935,325 | – | $146.05M | 1.84% | Jul 31, 2026 |
| Dimensional International Value ETF | 888,855 | – | $138.79M | 0.65% | Jul 31, 2026 |
| Franklin Mutual Shares Fund | 812,618 | – | $127.35M | 1.83% | Jun 30, 2026 |
| Dimensional International Core Equity Market ETF | 753,095 | – | $117.60M | 0.67% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 719,088 | – | $112.29M | 0.76% | Jul 31, 2026 |
| Vanguard Primecap Core Fund | 669,790 | – | $104.97M | 0.58% | Jun 30, 2026 |
| Lord Abbett Affiliated Fund Inc | 667,989 | – | $104.31M | 1.52% | Jul 31, 2026 |
| Avantis International Equity ETF | 612,686 | – | $92.01M | 0.54% | May 31, 2026 |
| VanEck Pharmaceutical ETF | 596,253 | – | $93.44M | 10.63% | Jun 30, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
5M shares short
Days to cover
1.9
At 2M shares a day
Change since last report
-19.2%
From 6M shares
Short volume, 20 days
50.0%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Novartis's stock actually held short. Settlement fails (shares not delivered on time) peaked at 72,516 shares on Aug 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Bulto Carulla Victor Officer | Oct 28, 2026 | 6,000 | $933.18K | Oct 28, 2026 | Restricted Stock Vesting |
| Bulto Carulla Victor Officer | Apr 30, 2026 | 6,800 | $1.01M | Apr 30, 2026 | Restricted Stock Vesting |
| Marshall Fiona Officer | Feb 12, 2026 | 30,743 | $4.96M | Feb 12, 2026 | Restricted Stock Vesting |
| Bulto Carulla Victor Officer | Feb 9, 2026 | 7,500 | $1.17M | Feb 9, 2026 | Restricted Stock Vesting |
| Marshall Fiona Officer | May 23, 2025 | 15,000 | $1.69M | May 23, 2025 | Restricted Stock Vesting |
| Kowalski Robert William Officer | Apr 30, 2025 | 1,212 | $137.30K | Apr 30, 2025 | Restricted Stock Vesting |
| Kowalski Robert William Officer | Aug 12, 2024 | 6,566 | $733.57K | Aug 12, 2024 | Restricted Stock Vesting |
| Gal Aharon Officer | May 22, 2024 | 2,500 | $254.83K | May 22, 2024 | Open Market Purchase |
| Kowalski Robert William Officer | Sep 19, 2023 | 1,581 | $162.73K | Sep 19, 2023 | Restricted Stock Vesting |
See a number that looks wrong?